Our Technology Was Developed at the University of Minnesota and Is Patented Worldwide
It provides definitive, enhanced-sensitivity point-of-care (POC) diagnostic results, whether in physicians' offices, consumers’ homes, workplaces, or any location.
Now, clinicians, caregivers, even consumers will be able to get immediate diagnosis for diseases such as Malaria, Influenza, Strep, STIs, HIV, COVID-19, and more.
Meaning faster clinical action assessments and coordination of care for immediate treatment, improving quality of care and saving considerable time and money.
Our technology greatly reduces false negatives, eliminating the need for confirmatory testing, speeding treatment, and reducing healthcare costs.
What’s more, it requires no change for users to their diagnostic test workflow.
The ultimate benefit is a substantial reduction in the economic burden of infectious diseases on society.